1Ma Q, Dang G, Ma D. An experimental study on BMP gene expression invivo. Chung Hua Wai Ko Tsa Chih, 1996, 34(10) : 582 - 584.
2Haimanti D, Kuber S. Bone morphogenetic protein- 7 modulates genes that maintain the vascular smooth muscle cell phenotype in culture. J Bone Joint Surg Am, 2001, 83(A)S1:70- 78.
3Centrella M, Horowitz MC, Wozney JM, et al. Transforming growth factor- β gene family member and bone. Endoc Bev,1994,15:27.
4Spean MB, Roberts AB. Peptide growth factors and their receptors. New York: Sprinter Verlag, 1991,371 - 388.
5Spore MB, Roberts AB. Peptide growth factors and flammation, tissue repair and cancer. J Clin Invest, 1986, 78: 329.
6Centrella M, Mc Cathy TL, Canalis E. Transforming growth factor- β and remodeling of bone. J Bone Joint Surg Am,1991, 73(A) :1418 - 1428.
7Allen RE, Boxhorn LK. Regulation of skeletal muscles atellite cell proliferation by transforming growth factor- beta, insulin -like growth factorl and flbroblast growth factor. J Cell Phys Iol,1989,138:311 ~ 315.
8Bonewald LF . Role of transforming growth factor -beta in bone remodeling. Clin Orthop Relat Res, 1990, 250:261.
9Ibbotson K J, Orcutt CM, Anlln AM, et al. Effects of transforming growth factors- beta and mouseclonal. Osteoblast likecells line MC3T3E. J Bone Miner Res,1996,4(1) :37- 45.
10Vogel KG, Hernandez DJ. The effects of transforming growth factor - beta and serum on proteoglycan synthesis by tendon fibrocartilage. Eur J Cell Biol, 1992,59:304-313.
